The use of functional foods in children

Cover Page

Cite item

Full Text

Abstract

The article presents the concept of functional nutrition through which general health improvement of the organism takes place. The functional components of nutrition are vitamins, carotenoids, micro- and macronutrients (calcium, magnesium, sodium, potassium, iron, iodine, selenium), dietary fiber, protein hydrolysates, polyunsaturated fatty acids, probiotics and prebiotics. The concept of functional nutrition has been developing in Russia since 1993, and these ideas were enshrined in law in 1998. Specialized products for children are created taking into account age, safety of ingredients, balance of fats, proteins and carbohydrates, vitamins, microelements, with addition of pro- and prebiotics.

Full Text

Restricted Access

About the authors

Irina N. Zakharova

Russian Medical Academy of Continuous Professional Education

Author for correspondence.
Email: zakharova-rmapo@yandex.ru
ORCID iD: 0000-0003-4200-4598

D. Sci. (Med.), Prof.

Russian Federation, Moscow

Irina V. Berezhnaia

Russian Medical Academy of Continuous Professional Education

Email: zakharova-rmapo@yandex.ru

Cand. Sci. (Med.)

Russian Federation, Moscow

Aleksandra I. Sgibneva

Pirogov Russian National Research Medical University

Email: Asgibneva470@gmail.com

Student

Russian Federation, Moscow

References

  1. Гиппократ. Сочинения в трех томах. Пер. с греч. В.И. Руднева. Ред. и прим. В.П. Карпова. М.: Медгиз, 1944 [Hippocrates. Works in three volumes. Translate from Greek V.I. Rudnev. Ed. and approx. V.P. Karpov. Moscow: Medgiz, 1944 (in Russian)].
  2. Певзнер М.И. Основы лечебного питания. М., 1958 [Pevzner MI. Fundamentals of medical nutrition. Moscow, 1958 (in Russian)].
  3. Национальная программа оптимизации вскармливания детей первого года жизни в Российской Федерации. Под ред. А.А. Баранова. М., 2019 [National program for optimization of feeding of children of the first year of life in the Russian Federation. Ed. A.A. Baranov. Moscow, 2019 (in Russian)].
  4. Available at: http://fgosvo.ru/190405
  5. WGO Global Guideline Probiotics and prebiotics. 2017.
  6. Grossi E, Buresta R, Abbiati R, Cerutti R, Pro-DIA study group. Clinical trial on the efficacy of a new symbiotic formulation, Flortec, in patients with acute diarrhea: a multicenter, randomized study in primary care. J Clin Gastroenterol 2010; 44 (Suppl. 1): S35–41.
  7. Hempel S, Newberry SJ, Maher AR, et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA 2012; 307 (18): 1959–69.
  8. Dang Y, Reinhardt JD, Zhou X, Zhang G. The effect of probiotics supplementation on Helicobacter pylori eradication rates and side effects during eradication therapy: a metaanalysis. PloS One 2014; 9 (11): e111030.
  9. Ojetti V, Bruno G, Ainora ME, et al. Impact of Lactobacillus reuteri Supplementation on Anti-Helicobacter pylori Levofloxacin-Based Second-Line Therapy. Gastroenterol Res Pract 2012; 2012: 740381.
  10. Allen SJ, Martinez EG, Gregorio GV, Dans LF. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev 2010; 11: CD003048.
  11. Höchter W, Hagenhoff G. Saccharomyces boulardii in acute adult diarrhea: efficacy and tolerability of treatment. Munch Med Wochenschr 1990; 132: 188–92.
  12. Goldenberg JZ, Ma SSY, Saxton JD, et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev 2013; 5: CD006095.
  13. Choi CH, Jo SY, Park HJ, et al. A randomized, doubleblind, placebo-controlled multicenter trial of saccharomyces boulardii in irritable bowel syndrome: effect on quality of life. J Clin Gastroenterol 2011; 45 (8): 679–83.
  14. Cimperman L, Bayless G, Best K, et al. A randomized, doubleblind, placebo-controlled pilot study of Lactobacillus reuteri ATCC 55730 for the prevention of antibiotic-associated diarrhea in hospitalized adults. J Clin Gastroenterol 2011; 45 (9): 785–9.
  15. Ducrotté P, Sawant P, Jayanthi V. Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome. World J Gastroenterol 2012; 18 (30): 4012–8.
  16. Ford AC, Quigley EMM, Lacy BE, et al. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. Am J Gastroenterol 2014; 109 (10): 1547–61; quiz 1546, 1562.
  17. Whorwell PJ, Altringer L, Morel J, et al. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol 2006; 101 (7): 1581–90.
  18. Moayyedi P, Ford AC, Talley NJ, et al. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut 2010; 59 (3): 325–32.
  19. Jafari E, Vahedi H, Merat S, et al. Therapeutic effects, tolerability and safety of a multi-strain probiotic in Iranian adults with irritable bowel syndrome and bloating. Arch Iran Med 2014; 17 (7): 466–70.
  20. Lorenzo-Zúñiga V, Llop E, Suárez C, et al. I.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life. World J Gastroenterol 2014; 20 (26): 8709–16. doi: 10.3748/wjg.v20.i26.8709
  21. Acharya MR, Shah RK. Selection of human isolates of Bifidobacteria for their use as probiotics. Appl Biochem Biotechnol 2002; 102–3 (1–6): 81–98.
  22. Matsumoto M, Ohishi H, Benno Y. H+-ATPase activity in Bifidobacterium with special reference to acid tolerance. Int J Food Microbiol 2004; 93 (1): 109–13.
  23. Holscher HD, Czerkies LA, Cekola P, et al. Bifidobacterium lactis Bb12 enhances intestinal antibody response in formula-fed infants: a randomized, double-blind, controlled trial. JPEN J Parenter Enteral Nutr 2012; 36 (1): 106S–117S.
  24. EFSA (European Food Safety Authority). Scientific Opinion on the maintenance of the list of QPS biological agents intentionally addede to food and feed (2010 update). EFSA Journal 2010; 8: 1–56.
  25. FAO/WHO. Health and Nutrition Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria. 2001.
  26. FAO/WHO. Guidelines for the Evaluation of Probiotics in Food. Report of a joint FAO/WHO working group on drafting guidelines for the evaluation of probiotics in food. Joint FAO/WHO Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food. 2002.
  27. Nishida S, Gotou M, Akutsu S, et al. Effect of Yogurt Containing Bifidobacterium lactis BB-12 on Improvement of Defecation and Fecal Microflora of Healthy Female Adults. Milk Science 2004; 53: 71–80.
  28. Matsumoto M, Imai T, Hironaka T, et al. Effect of Yoghurt with Bifidobacterium lactis LKM512 in Improving Fecal Microflora and Defecation of Healthy Volunteers. Intestine Microbiology Magazine 2001; 14: 97–102.
  29. Chouraqui JP, Van Egroo LD, Fichot MC. Acidified milk formula supplemented with bifidobacterium lactis: impact on infant diarrhea in residential care settings. J Pediatr Gastroenterol Nutr 2004; 38: 288–92.
  30. Saavedra JM, Bauman NA, Oung I, et al. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 1994; 344: 1046–9.
  31. Bhalla A. Randomized placebo-controlled, double blind, Multicentric Trial on Efficacy and Safety of Providac techsules (Lactobacillus acidophilus LA-5 and Bifidobacterium BB-12) for prevention of Antibiotic-Associated Diarrhea in Indian patients. ACCP. 2011; Chicago, Illinois.
  32. Sheu BS, Wu JJ, Lo CY, et al. Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther 2002; 16: 1669–75.
  33. McFarland LV, Huang Y, Wang L, Malfertheiner P. Systematic review and meta-analysis: Multi-strain probiotics as adjunct therapy for Helicobacter pylori eradication and prevention of adverse events. United European Gastroenterol J 2016; 4 (4): 546–61. doi: 10.1177/2050640615617358
  34. Rizzardini G, Eskesen D, Calder PC, et al. Evaluation of the immune benefits of two probiotic strains Bifidobacterium animalis ssp. lactis, BB-12® and Lactobacillus paracasei ssp. paracasei, L. casei 431® in an influenza vaccination model: a randomised, doubleblind, placebo-controlled study. Br J Nutr 2012; 107: 876–84.
  35. Holscher HD, Czerkies LA, Cekola P, et al., Bifidobacterium lactis Bb12 Enhances Intestinal Antibody Response in Formula‐Fed Infants. JPEN 2012; 36 (Suppl. 1): 106S–17S. doi: 10.1177/0148607111430817
  36. Smith TJ, Rigassio-Radler D, Denmark R, et al. Effect of Lactobacillus rhamnosus LGG(R) and Bifidobacterium animalis ssp. lac tis BB-12(R) on health-related quality of life in college students affected by upper respiratory infections. Br J Nutr 2012; p. 1–9.
  37. Rautava S, Salminen S, Isolauri E. Specific probiotics in reducing the risk of acute infections in infancya randomised, doubleblind, placebocontrolled study. Br J Nutr 2009; 101: 1722–6.
  38. Taipale T, Pienihakkinen K, Isolauri E, et al. Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in infancy. Br J Nutr 2011; 105: 409–16.
  39. Stratiki E, Sevastiadou S, Stamouli K, et al. Effect of oral Bifidobacterium lactis on the intestinal permeability and the growth of preterm infants. 2nd Congress of the European Academy of Paediatrics Congress (Europediatrics), Barcelona, Spain, October 2006. Abstract.
  40. Nabavi S, Rafraf M, Somi MH, et al. Effects of probiotic yogurt consumption on metabolic factors in individuals with nonalcoholic fatty liver disease. J Dairy Sci 2014; 97 (12): 7386–93.
  41. Isolauri E, Arvola T, Sütas Y, et al. Probiotics in the management of atopic eczema. Clin Exp Allergy 2000; 30 (11): 1604–10.
  42. Некрасова Н.В., Спиркина Е.Р., Некрасова П.В. Пробиотики в лечении атопического дерматита у детей. Клинический опыт. Медицинский совет. 2020; 1: 145–50 [Nekrasova NV, Spirkina ER, Nekrasova PV. Probiotiki v lechenii atopicheskogo dermatita u detei. Klinicheskii opyt. Meditsinskii sovet. 2020; 1: 145–50 (in Russian)]. doi: 10.21518/2079-701X-2020-1-145-150
  43. Дмитриева Ю.А., Захарова И.Н., Сугян Н.Г., Бережная И.В. Современная практика введения продуктов прикорма: Кому? Когда? Сколько? Медицинский совет. 2017; 19: 44–50 [Dmitrieva Iu.A., Zakharova I.N., Sugian N.G., Berezhnaia I.V. Sovremennaia praktika vvedeniia produktov prikorma: Komu? Kogda? Skol’ko? Meditsinskii sovet. 2017; 19: 44–50 (in Russian)].
  44. Carty TLM, Kerry JP, Kerry JF, et al. Evaluation of the antioxidant potential of natural food / plant extracts compared to synthetic antioxidants and vitamin E in raw and cooked pork cutlets. Meat Sci 2015; 1: 45–52.
  45. Chen J, Lindmark-Mansson H, Akesson B. Optimization of a coupled enzymatic assay for glutathione peroxidase activity in bovine milk and serum. Int Dairy J 2000; p. 347–51.
  46. Matter AA, Mahmoud EAM, Zidane NS. Fruit flavored yoghurt: chemical, functional and rheological properties. Inter J Enviro Agric Res 2016; 2: 57–66.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2021 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 74329 от 19.11.2018 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies